Expert in DNA Sequencing: Next-Generation Sequencing (NGS)
Lastly, he provides consulting services for all the major players in expert consultancy, so he is very experienced in all aspects of telephone consulting for both investors and analysts, not the least being adherence to regulatory restrictions.
He has consulted for all the large expert networks on the DNA analysis business including about 150 phone calls to investors and analysts at many of the top firms.Patent advice to lawyers and companies - claims analysis, prosecution, interference, etc.
Expert may consult nationally and internationally, and is also local to the following cities: New York, New York - Yonkers, New York - Newark, New Jersey - Jersey City, New Jersey - Paterson, New Jersey - Elizabeth, New Jersey - Bridgeport, Connecticut - New Haven, Connecticut - Hartford, Connecticut - Philadelphia, Pennsylvania
|Year: 1991||Degree: Ph.D.||Subject: Bioengineering||Institution: University of Utah|
|Year: 1979||Degree: BS||Subject: Physics and math||Institution: University of California, Santa Cruz, CA|
|Years: 2014 to Present||Employer: Undisclosed||Title: VP of Sequencing||Department: Operations||Responsibilities: Expert runs the production sequencing operation for one of the largest sequencing facilities. He also manages the clinical operations and the technology innovation (R+D) teams.|
|Years: 2008 to 2014||Employer: The Wellcome Trust Sanger Institute||Title: Head of Research and Development (R+D)||Department: Sequencing||Responsibilities: He directs a large R+D group that delivers custom molecular biology tools for next-generation DNA sequencing; testing and development of early access sequencing instruments.|
|Years: 2006 to 2007||Employer: The Dolomite Centre, Ltd., U.K.||Title: Chief Technology Officer (CTO)||Department:||Responsibilities: Set-up of a new entity using UK Department of Trade and Industry funding. Dolomite's goal is to develop a glass and quartz microfabrication and microfluidics design and development centre unique in the UK. Business development and management of key projects in all areas of science and especially focussing on applications in PCR, DNA analysis and sequencing.|
|Years: 2000 to 2006||Employer: Solexa, Ltd. U.K||Title: Senior Director of Research||Department:||Responsibilities: Contributed to the development of Solexa's first product through to early-access launch in 2006. Other responsibilities included optimisation of DNA sequencing protocols and oversight of next-generation technologies; enhanced fluorescent detection methods, improved instrumentation and advanced biochemical strategies for DNA sequencing.|
|Years: 1998 to 2000||Employer: Center for Genomics Res. Karolinska Inst.||Title: Unit Coordinator (Genomics Technologies Unit) and Director of the Microarray Core Facility||Department: Center for Genomics Research||Responsibilities: Microchip-based DNA analysis; microfluidic system design; functional genomics; design and development of automated capillary electrophoresis instrumentation; breast-cancer diagnostics.
|Years: 1991 to 1998||Employer: Human Genetics, Univ. of Utah||Title: Research Assistant Professor, formerly Post-doctoral Research Associate||Department: Department of Human Genetics||Responsibilities: Use of microfluidic technology and microfabrication to solve problems in molecular biology; automated DNA sequencing instrumentation; DNA-based diagnosis of genetic diseases; analytical chemistry for genomics applications; polymer and surface chemistry. Capillary fluidics-based diagnostics; DNA-sequencing technology development.
|Associations / Societies|
|SAB member for 2 next-generation sequencing companies (ZS Genetics and Noblegen)
|Publications and Patents Summary|
|He has 44 publications and is an inventor on 13 issued patents|
|Expert Witness Experience|
|I have evaluated patents for legal clients and prepared technical reports. But have no direct trial experience.|
|Training / Seminars|
|Wellcome Trust Advanced Course in Next-Generation DNA sequencing|
|Have worked with all the main instrument providers for DNA sequencing|
|Market drivers, funding environment and future trends in next-generation sequencing|
|Other Relevant Experience|
|Investor and Analyst consultations on a regular basis.|